ProSolv® Extends Nuclear Cardiology Capabilities With Corridor 4DM for Nuclear SPECT
by Barbara Kram, Editor | September 10, 2007
San Diego, Calif. - At the 12th Annual Scientific Session of the American Society of Nuclear Cardiology (ASNC), ProSolv® CardioVascular, a FUJIFILM company (ProSolv) announced that it has further enhanced its CardioVascular Image and Information Systems (CVIIS) product line with the integration of Corridor4DM (previously known as 4DM-SPECT) capabilities. Nuclear cardiology physicians and technologists can benefit from access to 4DM review, analysis, and quantification tools from any ProSolv CardioVascular workstation for reporting and image management, at any location, streamlining workflow and improving productivity.
"Our goal is to provide a truly integrated cardiovascular image and information solution across all sub-specialties," said Aaron Waitz, President and CEO of ProSolv® CardioVascular. "With this enhancement we're pleased to extend the capabilities of our cardiovascular portfolio and further strengthen our offering. Coupled with our unrivaled structured reporting, we're able to truly differentiate ourselves in the market," Waitz continued.
ProSolv's enhanced nuclear cardiology capabilities are a result of the integration of Corridor4DM for Nuclear SPECT, a state-of-the-art cardiac analysis software suite from INVIA Medical Imaging Solutions into the ProSolv CardioVascular software. Because ProSolv offers a vendor- and hardware-neutral, software-only solution, the integration provides one user-friendly, intuitive environment within which the user - technologist or physician - can efficiently process and review all cardiac emission computed tomographic (ECT) perfusion studies. The studies can be accessed from any ProSolv workstation with a single logon, untethering users from the nuclear lab.
In addition to accessing the complete history of cardiac studies across modalities, the integration also provides access to all reporting information, making the process more efficient from diagnosis through billing. ProSolv's advanced structured reporting capabilities will include default templates that follow the American Society of Nuclear Cardiology (ASNC) guidelines and stringent standards set forth by the Intersocietal Commission for the Accreditation of Nuclear Medicine Laboratories (ICANL). This provides assurances that the clinical report includes all recommended elements. Additionally, with ProSolv's database mining, initial and on-going statistical reporting required for accreditation is accurate and less time consuming. Correlation requirements for nuclear cardiology - when used in conjunction with the entire portfolio of ProSolv multi-modality reporting modules - are also easy to gather and ensured to be accurate.
"Our goal is to provide a truly integrated cardiovascular image and information solution across all sub-specialties," said Aaron Waitz, President and CEO of ProSolv® CardioVascular. "With this enhancement we're pleased to extend the capabilities of our cardiovascular portfolio and further strengthen our offering. Coupled with our unrivaled structured reporting, we're able to truly differentiate ourselves in the market," Waitz continued.
ProSolv's enhanced nuclear cardiology capabilities are a result of the integration of Corridor4DM for Nuclear SPECT, a state-of-the-art cardiac analysis software suite from INVIA Medical Imaging Solutions into the ProSolv CardioVascular software. Because ProSolv offers a vendor- and hardware-neutral, software-only solution, the integration provides one user-friendly, intuitive environment within which the user - technologist or physician - can efficiently process and review all cardiac emission computed tomographic (ECT) perfusion studies. The studies can be accessed from any ProSolv workstation with a single logon, untethering users from the nuclear lab.
In addition to accessing the complete history of cardiac studies across modalities, the integration also provides access to all reporting information, making the process more efficient from diagnosis through billing. ProSolv's advanced structured reporting capabilities will include default templates that follow the American Society of Nuclear Cardiology (ASNC) guidelines and stringent standards set forth by the Intersocietal Commission for the Accreditation of Nuclear Medicine Laboratories (ICANL). This provides assurances that the clinical report includes all recommended elements. Additionally, with ProSolv's database mining, initial and on-going statistical reporting required for accreditation is accurate and less time consuming. Correlation requirements for nuclear cardiology - when used in conjunction with the entire portfolio of ProSolv multi-modality reporting modules - are also easy to gather and ensured to be accurate.
1(current)
